Gene Query: SLC4A4

Dataset Description Geneva Score
Expression by CD133+ cells isolated from the adult human exocrine pancreas 85.5
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 82.0
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 73.53
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 73.03
Role of CD133 molecule in WNT response and renal repair 67.53
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 67.3
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 60.99
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 60.99
Ebola virus (EBOV) infection of ARPE-19 cells 47.28
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 47.13
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 47.01
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 46.51
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 46.51
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 45.44
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 45.44
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 44.68
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 42.79
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 42.11
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 41.8
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 40.83
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 40.57
Differential gene expression in Jagged1 treated human dental pulp cells. 39.02
RNA-seq analyses of human prostate cancer cells 38.49
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 38.22
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 38.11
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 38.11
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 36.09
Differential expression of genes in AD169-infected MRC5. 35.09
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 34.56
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 33.46
RNA-seq of human fibroblasts after irradiation 33.24
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 33.22
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 32.31
Transcriptomic and gene ontology profiling of the human corneal cell types 32.09
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 31.36
LNCaP treated with iBET 31.11
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 30.83
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 30.5
Nucleoporin-mediated regulation of cell identity genes 30.33
Genome-wide identification of cancer-specific alternative splicing in circRNA 29.45
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 28.91
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 28.22
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 28.09
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 27.91
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 27.78
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 26.12
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 26.06
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 25.46
AR-independent prostate cancer is sustained through FGF signaling 25.14
A prostate cancer chromatin interaction map 25.07
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 24.58
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 24.16
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 23.9
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 23.67
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 23.6
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 23.23
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 22.31
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 22.3
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 22.3
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 22.24
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 22.21
RNA sequencing of matched nephrectomy samples [RNA-seq] 22.21
Investigation about fibroblasts of different origins in culture 22.21
Tracing Enhancer Networks using Epigenetic Traits (TENET) 21.86
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 21.85
RNA-seq in HepG2 and IMR90 cells 21.35
Evolution of a transcriptional regulator from a transmembrane nucleoporin 21.35
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 21.18
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 21.18
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 21.12
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 21.06
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 21.0
Regionally specified human pluripotent stem cell-derived astrocytes 20.88
FOXP1 orchestration of ASD-relevant signaling pathways. 20.73
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 20.57
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 20.57
Transcriptional profiling of microglia; current state of the art and future perspectives 20.28
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 19.41
Functional astrocytes differentiated from hiPSCs 19.25
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 19.25
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 19.24
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 19.18
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 19.18
Universal alternative splicing of noncoding exons 19.11
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 18.78
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 18.76
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 18.71
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 18.67
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 18.56
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 18.53
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 17.98
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 17.97
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 17.38
Paxillin regulates genomic networks in prostate cancer [C4-2] 17.22
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 16.81
Lipid degradation promotes prostate cancer cell survival 16.78
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 16.61
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 16.34
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 16.31
EGR1-controlled transcriptome of T HESCs 16.16
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 16.08
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 15.89
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 15.85
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 15.69
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 15.69
Toxoplasma gondii infection of human retinal pigment epithelial cells 15.64
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 15.61
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 15.58
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 15.33
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 15.2
Total RNA-seq in ALL-SIL upon JQ1 inhibition 14.88
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 14.64
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 14.61
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 14.46
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 14.37
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 14.37
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 14.21
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 14.21
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 14.18
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 14.14
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 13.94
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 13.88
RNA-sequencing 13.85
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 13.82
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 13.82
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 13.6
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 13.19
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 13.16
PNET animal model: new insights (II) 13.08
Gene expression profile difference among renal location in a stone former 13.06
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 13.01
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 12.66
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 12.6
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 12.36
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 12.26
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 12.26
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 12.22
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 12.16
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 11.97
Effect of mitochondria deficiency on senescence-associated gene expression 11.93
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 11.88
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 11.86
Expression level comparison under dividing and quiescent states in human primary fibroblasts 11.83
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 11.79
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 11.79
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 11.78
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 11.72
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 11.62
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 11.52
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 11.5
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 11.25
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 11.0
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 10.98
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 10.95
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 10.89
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 10.61
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 10.49
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 10.45
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 10.35
Effect of PBK knockdown on C4-2 cell transcriptome 10.31
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 10.28
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 10.25
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 10.21
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 10.17
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 10.12
Gene expression analysis of human hepatocellular cancers 10.06
circNFIB suppresses lymphatic metastasis of pancreatic cancer 9.92
Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain 9.81
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 9.78
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 9.69
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 9.61
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 9.5
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 9.49
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 9.49
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 9.46
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 9.45
Effect of CHKA knockdown on C4-2 cell transcriptome 9.26
Electronic cigarettes 9.23
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 9.21
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 9.2
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 9.17
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 9.11
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 9.05
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 9.03
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 9.0
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 9.0
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 8.94
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 8.93
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 8.93
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 8.77
STX4 Over-Expression in Human islets 8.68
Irf9 function in immunity in mouse 8.44
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 8.44
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 8.42
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 8.37
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 8.35
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 8.34
Hijacking of stress response machinery by oncogenes in acute leukaemia 8.34
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 8.34
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 8.34
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 8.34
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 8.29
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 8.29
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 8.25
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 8.25
RNA Sequencing of three pairs of gastric cancer 8.13
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 8.12
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 8.09
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 8.09
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 8.04
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 8.0
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 7.97
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 7.97
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 7.94
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 7.88
circRNA-sequencing 7.86
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 7.81
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 7.77
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 7.75
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 7.63
Noncoding regions are the main source of targetable tumor-specific antigens 7.61
Single cell transcriptome of peritoneal cells 7.53
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 7.5
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 7.49
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 7.47
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 7.41
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 7.39
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 7.39
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 7.39
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 7.33
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 7.31
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 7.29
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 7.28
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 7.28
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 7.26
RNA sequencing of hPSC-derived cardiac progenitors and endocardium 7.24
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 7.24
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 7.21
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 7.17
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 7.13
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 7.11
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 7.04
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 7.0
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 7.0
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 6.99
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 6.98
Identification of a LIF-responsive replication-competent human β cell 6.92
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 6.88
RNAseq of T-ALL upon long non coding rna purturbation 6.7
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 6.69
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 6.68
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 6.61
Global epigenomic reconfiguration during mammalian brain development 6.48
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 6.46
Persistence of stem cell metabolism in cancers as a failure of differentiation 6.46
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 6.43
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 6.43
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 6.42
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 6.42
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 6.35
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 6.34
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 6.31
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 6.29
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 6.26
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 6.26
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 6.26
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 6.26
Genome-wide chromatin analysis of Ewing sarcoma 6.26
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 6.26
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 6.17
Induced DNA demethylation, genome instability and transcription 6.16
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 6.16
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 6.16
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 6.13
Differential analysis of gene regulation at transcript resolution by RNA-Seq 6.13
Gene expression analysis of human adenomas. 6.11
Reprogrammed myeloid cell transcriptomes in NSCLC 6.05
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 6.04
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 6.03
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 6.03
Transciptomic profiling of human fetal lung samples 6.02
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 5.88
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 5.87
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 5.85
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 5.83
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 5.83
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 5.83
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 5.79
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 5.79
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 5.76
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 5.74
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 5.74
Novel Targeting of Transcription and Metabolism in Glioblastoma 5.73
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 5.68
LINE-2 transposable elements are a source of functional human microRNAs and target sites 5.66
Total RNA sequencing of WT intestinal orgaonids. 5.65
Tyrosine Kinase Inhibitor Cardiotoxicity 5.62
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 5.62
Expression profiling of etoposide-induced senescent cells 5.6
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 5.6
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 5.56
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 5.55
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 5.46
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 5.4
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 5.39
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 5.31
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 5.24
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 5.23
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 5.19
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 5.15
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 5.1
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 5.09
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 5.03
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 5.03
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 4.94
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 4.91
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 4.87
The age and genomic integrity of neurons after cortical stroke in humans 4.86
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 4.84
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 4.84
Activity-dependent transcriptional changes in human neurons 4.83
Disruption of GRIN2B impairs differentiation in human neurons 4.79
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 4.75
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 4.73
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 4.71
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 4.63
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 4.62
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 4.6
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 4.57
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 4.56
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 4.55
RNA-seq analysis of the human fetal kidney. 4.54
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 4.52
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 4.52
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 4.43
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 4.4
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 4.39
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 4.36
RNA seq analysis of human Fetal and adult derived Enterospheres 4.34
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 4.24
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 4.23
mRNA-Seq profiling of human developing kidney 4.22
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 4.15
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 4.14
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 4.08
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 4.05
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 4.05
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 4.0
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 3.88
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 3.88
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 3.82
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 3.82
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 3.81
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 3.81
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 3.76
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 3.56
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 3.54
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 3.51
Common inflammatory pathways between NEC and Crohn's disease 3.49
X-Ray induced DNA-Hydroxymethylation changes 3.42
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 3.35
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 3.34
Glioblastoma stem cells infected by ZIKA virus 3.32
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 3.32
Genome-wide Analysis of Chromatin Interactions in Human Cells 3.26
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 3.21
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 3.21
The gene expression profiles of gallbladder cancer 3.18
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 3.14
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 3.14
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 3.13
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 3.13
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 3.07
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 3.07
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 3.06
ML29755 RNA-seq data 3.03
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 3.01
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 2.98
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 2.98
RNA-Seq with and without RNase treatment in PCa cell lines 2.96
Identification of renal resident macrophages across species [C1] 2.91
Gene expression of collecting duct carcinoma of the kidney 2.91
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.89
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 2.83
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 2.81
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 2.81
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 2.8
The expression profiles of GBC liver metastasis 2.7
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 2.7
Dissecting neural differentiation regulatory networks through epigenetic footprinting 2.64
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 2.6
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 2.58
Transcriptome analysis reveals differential splicing events in IPF lung tissue 2.58
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 2.56
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 2.49
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.46
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 2.42
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 2.42
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 2.42
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 2.4
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 2.36
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 2.34
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 2.32
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 2.32
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 2.31
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 2.27
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 2.26
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 2.25
Measure transcript integrity using RNA-seq data 2.25
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 2.2
Human islets of varying quality: the good, the (not so) bad and the ugly 2.17
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 2.17
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 2.15
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.14
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 2.11
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 2.09
Human optic chiasm from healthy controls and multiple sclerosis patients 2.02
Multiple sclerosis and EAE 2.02
The role of CFTR in islet function 1.96
Identification of expressed and conserved human non-coding RNAs 1.91
Gene expression of thyroid cancer cell lines 1.91
Gene expression profiling of KSHV-infected periodontal ligament cells 1.89
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 1.88
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.83
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 1.83
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 1.73
RNA Sequencing of Human iPS derived Cardiomyocytes 1.72
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 1.72
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 1.69
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.68
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.68
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 1.66
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 1.66
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 1.57
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 1.57
The Glioma-Infiltrating T Cell Receptor Repertoire 1.54
RNA-Seq of the corpus callosum from 12 individuals 1.54
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 1.45
A single-cell transcriptome atlas of the human pancreas 1.36
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.33
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 1.33
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 1.3
RNAseq in Alzheimer's Disease patients 1.26
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 1.25
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.23
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 1.15
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 1.06
Epigenome regulation during epidermal lineage commitment [RNA-seq] 1.05
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.05
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 1.04
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 1.04
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.96
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.96
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.91
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 0.82
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.79
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.75
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 0.73
Gene expression profiling in metabolically heterogeneous human lung tumors 0.71
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.71
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.68
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.68
BET bromodomain inhibition 0.66
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 0.66
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.58
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.56
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.54
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 0.5
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 0.48
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 0.48
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 0.48
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 0.47
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.41
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.41
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.4
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.37
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.37
Zone dependent distinctive gene expression profile of the normal human liver tissue 0.36
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.35
N6-methyladenine DNA Modification in Glioblastoma 0.35
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.31
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.31
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.3
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 0.28
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 0.28
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 0.23
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.21
CDK4/6 inhibitor resistance in prostate cancer 0.21
Transcriptome analyses of human pancreatic islets and pseudoislets 0.2
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.17
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.15
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.13
An optimization system for isolating and sequencing of single human colon cancer cells 0.07
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.05
Transcriptome of human white and brown adipose tissue biopsies 0.05
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 0.04
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.02
Oncogenic roles of ARID5B in T-ALL 0.02
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.01
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation